Patterns of Sacral Nerve Modulation Adoption: Impact of State Licensure, Region, and Urbanicity
Journal of Surgical Research · 2025
DOI: 10.1016/j.jss.2025.10.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Research, 2025. Verfasst von Basil Karam und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of California, San Francisco, California. Hauptthemen laut MEDLINE: Fecal Incontinence, Electric Stimulation Therapy, Lumbosacral Plexus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: University of California, San Francisco.
Abstract (Originalsprache)
INTRODUCTION: Sacral nerve modulation (SNM) is an effective therapy for fecal incontinence (FI), but its national utilization and access remain poorly understood. Regulatory and geographic factors may affect treatment adoption. METHODS: In this retrospective cohort study, the IBM MarketScan claims database (2014-2022) was used to identify commercially insured adults aged 18-65 y with persistent FI. Patients were stratified by state fluoroscopy licensing policies, census region, metropolitan residence, and age. Outcomes included SNM and ostomy placement. Fine-Gray competing risk models and Cox regression were used to estimate associations with state fluoroscopy licensing policies, adjusting for age, sex, region, and metro status. RESULTS: Among 62,167 patients, SNM was placed in 4.1%, while 1.1% underwent ileostomy/colostomy. Large metropolitan residence was associated with reduced SNM use (subdistribution hazard ratio (SHR): 0.70, 95% confidence interval (CI): 0.60-0.82; P < 0.001). Compared to the West, SNM use was significantly higher in only the South (SHR: 1.52, 95% CI: 1.21-1.90; P < 0.001). Fluoroscopy exam requirements, mandated only in California, did not significantly impact patient likelihood to undergo SNM compared to other states without requirements (SHR: 0.77, 95% CI: 0.53-1.12; P = 0.16). Adults aged ≥59 y were more likely to receive SNM than younger patients (SHR: 1.50, 95% CI: 1.32-1.70; P < 0.001). CONCLUSIONS: SNM is underutilized in the United States, with access significantly influenced by geography. Fluoroscopy examination mandates, regional differences in training density, and structural barriers in metropolitan and western areas may limit SNM adoption. Policy standardization and expanded training opportunities may help improve equitable access.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, University of California, San Francisco, California.
- Department of Epidemiology and Biostatistics, San Francisco, California.
- Department of Surgery, University of California, San Francisco, California. Electronic address: mark.zhao@ucsf.edu.
Förderung
- University of California, San Francisco
Zitieren
APA
Karam, B., Shui, A. M., Pandey, S., & Zhao, B. (2025). Patterns of Sacral Nerve Modulation Adoption: Impact of State Licensure, Region, and Urbanicity. Journal of Surgical Research. https://doi.org/10.1016/j.jss.2025.10.003
Vancouver
Karam B, Shui AM, Pandey S, Zhao B. Patterns of Sacral Nerve Modulation Adoption: Impact of State Licensure, Region, and Urbanicity. Journal of Surgical Research. 2025. doi:10.1016/j.jss.2025.10.003
BibTeX
@article{Karam2025,
author = {Karam, Basil and Shui, Amy M and Pandey, Shraddha and Zhao, Beiqun},
title = {Patterns of Sacral Nerve Modulation Adoption: Impact of State Licensure, Region, and Urbanicity},
journal = {Journal of Surgical Research},
year = {2025},
doi = {10.1016/j.jss.2025.10.003}
}
EUVIMED